Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 572 participants.

Also called NCT01426425

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 572 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01426425
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01426425. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2015-09 (actual). Results posted on 2017-03-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
Condition
AtrioVentricular Nodal Reentrant Tachycardia
Condition
Supraventricular Tachycardia
Condition
Heart Disease
Intervention (Device)
Freezor Xtra Cryoablation Catheter
Lead sponsor
Medtronic Cardiac Ablation Solutions (class: industry)

Record details

Record id
cardio:ct-nct01426425
Content hash
45088ca3df174793f445b4b2e91285deaf1b49a610edcde7f42a28ded4e1dd11